Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Labdane diterpene derivatives as well as pharmaceutical composition and application thereof

The technology of a derivative and a composition is applied in the field of helichanoid diterpene derivatives and pharmaceutical compositions thereof, which can solve the problems of high toxicity and poor activity, and achieve the effect of eliminating interference.

Active Publication Date: 2019-08-02
YUNNAN UNIV
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] Aiming at the technical problems of high toxicity and poor activity of inhibitors of the pronuclear factor-κB (NF-κB) signaling pathway in the prior art, it provides a helicanane-type diterpene derivative and its pharmaceutical composition and application, Banhelianthus Alkyl diterpene derivatives can inhibit NF-κB signaling pathway and treat various diseases mediated by NF-κB

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Labdane diterpene derivatives as well as pharmaceutical composition and application thereof
  • Labdane diterpene derivatives as well as pharmaceutical composition and application thereof
  • Labdane diterpene derivatives as well as pharmaceutical composition and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0047] Embodiment 1: the extraction method of helianthane type diterpene derivatives, the specific steps are as follows:

[0048] (1) Dry and pulverize the Leonurus branch;

[0049] (2) At room temperature, the motherwort sticks pulverized in step (1) were extracted 3 times with an aqueous ethanol solution with a volume fraction of 85%, each extraction was 24 hours, the ethanol extract was combined, filtered, and the filtrate was concentrated under reduced pressure get the extract;

[0050] (3) suspending the medicinal extract of step (2) in water, and extracting with sherwood oil, ethyl acetate and n-butanol successively to obtain sherwood oil extract, ethyl acetate extract and n-butanol extract;

[0051] (4) The ethyl acetate extract of step (3) is concentrated under reduced pressure to reclaim the solvent to obtain the ethyl acetate extract, then the ethyl acetate extract is dissolved in chloroform and adsorbed on silica gel, and the solvent chloroform is evaporated and gr...

Embodiment 2

[0125] Embodiment 2: The structural formula of embodiment 1 is the pharmacological experiment of I~XII helianthin type diterpene derivatives;

[0126] Cell culture: RAW264.7 cells (ATCC) gradually converge after growing for a period of time and cover the bottom of the bottle to form a monolayer cell membrane. When the coverage of adherent cells reaches 70-80% (about 1-2 days); Wash the cells once with PBS solution (Gibco fetal bovine serum), add 1 mL of trypsin (Gibco), digest at room temperature for 5 min, add 10 mL of DMEM complete medium containing 10% fetal bovine serum, blow off the cells, and culture in a cell incubator;

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses labdane diterpene derivatives as well as a pharmaceutical composition and application thereof, and belongs to the technical field of medicine. In the invention, based on the isolation of the labdane diterpene derivatives, it is confirmed that any one of the labdane diterpene derivatives having structural formulas I-XII as shown in the specification can be used as an inhibitor of a nuclear factor-kappaB (NF-kappaB) signal pathway, and can inhibit the NF-kappaB signal pathway and treat NF-kappaB-mediated diseases.

Description

technical field [0001] The invention relates to a helianthene-type diterpene derivative, a pharmaceutical composition and application thereof, and belongs to the technical field of medicines. Background technique [0002] Inflammatory response is a common clinical pathological process, and it is also the primary response measure of the immune system to harmful stimuli. Its symptoms often manifest as tissue redness, swelling, hair, heat, and pain. In general, inflammation is beneficial: exudates and tissue hyperplasia caused by inflammation dilute harmful stimuli and limit their spread; leukocytes in exudates destroy inflammatory factors and remove necrotic tissue. On the contrary, inflammation is also potentially harmful, which is manifested as: the degeneration and necrosis of vital organs caused by inflammation will seriously affect their normal functions, and excessive inflammatory responses may cause shock or multiple organ dysfunction. [0003] There are many stimuli t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D307/20C07D307/60C07D307/88C07D307/36C07C47/46C07C45/78C07C45/79C07C62/32C07C51/42C07C51/47A61K31/341A61K31/365A61K31/11A61K31/19A61P29/00A61P37/00A61P31/04A61P19/02A61P19/06
CPCC07D307/20C07D307/60C07D307/88C07D307/36C07C47/46C07C45/78C07C45/79C07C62/32C07C51/42C07C51/47A61P29/00A61P37/00A61P31/04A61P19/02A61P19/06C07C2602/28Y02A50/30
Inventor 肖伟烈张兴杰刘瑞雪张芮菡李晓莉秦华炎李一明
Owner YUNNAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com